Clinical Development

Q3 revenues dip for Pharsight

Q3 revenues dip for Pharsight

By Kirsty Barnes

Pharsight, a provider of software and strategic services for
clinical drug development, has seen its revenues dip for the second
quarter in a row due to lower-than-expected business from a top
client in its strategic consulting services...

Follow us

Products

View more

Webinars